SUPN Insider Trading Activity and SEC Form 4 Filings
Trump's trades in SUPN
From his financial disclosures
-
0 purchases
$30K+
2 sales
Sale
Jul 29, 2026
Reported 55d later
$15K - $50K
Sale
May 15, 2026
Reported 47d later
$15K - $50K
Many orders in these accounts are placed by the account manager.
SUPN insider trading summary
Over the past 12 months, insiders at Supernus Pharmaceuticals, Inc. (SUPN) reported 20 sales worth $10.3M by 7 insiders and no open-market purchases on SEC Form 4. Net insider selling was $10.3M.
Latest SUPN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 18, 2026 | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sell | $21K (412 @ $50.48) |
| Mar 18, 2026 | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sell | $339K (6,838 @ $49.55) |
| Mar 17, 2026 | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sell | $1.1M (22,290 @ $50.73) |
| Mar 17, 2026 | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sell | $1.4M (27,710 @ $49.95) |
| Mar 16, 2026 | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sell | $1.7M (34,114 @ $50.18) |
| Mar 16, 2026 | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sell | $802K (15,886 @ $50.49) |
| Mar 13, 2026 | Jack A. Khattar | President, CEO | Sell | $6K (120 @ $51.75) |
| Mar 13, 2026 | Jack A. Khattar | President, CEO | Sell | $548K (10,742 @ $51.00) |
| Mar 13, 2026 | Jack A. Khattar | President, CEO | Sell | $1.2M (24,138 @ $50.09) |
| Mar 12, 2026 | Frederick M. Hudson | Director | Sell | $272K (5,369 @ $50.61) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.